Peripheral arterial disease: The evolving role of non-invasive imaging

Postgraduate Medical Journal

Volumn 87, Issue 1025, 2011, Pages 189-198

  Owen, Andrew R ^a   Roditi, G H ^b  

^a GEELONG HOSPITAL   (Australia)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GADOBENATE DIMEGLUMINE; GADODIAMIDE; GADOLINIUM; GADOLINIUM PENTETATE; GADOTERATE MEGLUMINE; GADOTERIDOL; GADOVERSETAMIDE;

COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST INDUCED NEPHROPATHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIGITAL SUBTRACTION ANGIOGRAPHY; DUPLEX ULTRASOUND; HUMAN; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; MAGNETIC RESONANCE ANGIOGRAPHY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEPHROGENIC SYSTEMIC FIBROSIS; NON INVASIVE PROCEDURE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RADIATION DOSE; REVIEW; ULTRASOUND;

HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; PERIPHERAL ARTERIAL DISEASE; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 79952312361     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/pgmj.2009.082040     Document Type: Review

References (57)

1. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000;31:S1-296.
2. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)-summary of recommendations. J Vasc Interv Radiol 2006;17:1383-97.
3. Sacks D, Bakal CW, Beatty PT, et al. Position statement on the use of the ankle brachial index in the evaluation of patients with peripheral vascular disease. A consensus statement developed by the Standards Division of the Society of Interventional Radiology. J Vasc Interv Radiol 2003;14:S389.
4. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007;33(Suppl 1):S1-75.
5. Ota H, Takase K, Igarashi K, et al. MDCT compared with digital subtraction angiography for assessment of lower extremity arterial occlusive disease: importance of reviewing cross-sectional images. AJR Am J Roentgenol 2004;182:201-9. (Pubitemid 38017743)
6. Bosanac Z, Miller RJ, Jain M. Rotational digital subtraction carotid angiography: technique and comparison with static digital subtraction angiography. Clin Radiol 1998;53:682-7. (Pubitemid 28431977)
7. Singh H, Cardella JF, Cole PE, et al. Quality improvement guidelines for diagnostic arteriography. J Vasc Interv Radiol 2002;13:1-6. (Pubitemid 34094579)
8. Bradbury AW, Adam DJ. Diagnosis of peripheral arterial disease of the lower limb. BMJ 2007;334:1229-30.
9. Hingorani A, Ascher E, Marks N. Preprocedural imaging: new options to reduce need for contrast angiography. Semin Vasc Surg 2007;20:15-28. (Pubitemid 46453129)
10. Visser K, Hunink MG. Peripheral arterial disease: gadolinium-enhanced MR angiography versus color-guided duplex US-a meta-analysis. Radiology 2000;216:67-77. (Pubitemid 30434723)
11. Ouwendijk R, de Vries M, Stijnen T, et al. Multicenter randomized controlled trial of the costs and effects of noninvasive diagnostic imaging in patients with peripheral arterial disease: the DIPAD trial. AJR Am J Roentgenol 2008;190:1349-57. (Pubitemid 351684929)
12. Collins R, Burch J, Cranny G, et al. Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review. BMJ 2007;334:1257.
13. Kock MC, Dijkshoorn ML, Pattynama PM, et al. Multi-detector row computed tomography angiography of peripheral arterial disease. Eur Radiol 2007;17:3208-22. (Pubitemid 350142346)
14. Fleischmann D, Rubin GD. Quantification of intravenously administered contrast medium transit through the peripheral arteries: implications for CT angiography. Radiology 2005;236:1076-82. (Pubitemid 41170876)
15. Laswed T, Rizzo E, Guntern D, et al. Assessment of occlusive arterial disease of abdominal aorta and lower extremities arteries: value of multidetector CT angiography using an adaptive acquisition method. Eur Radiol 2008;18:263-72. (Pubitemid 351234045)
16. Cademartiri F, Luccichenti G, Marano R, et al. Use of saline chaser in the intravenous administration of contrast material in non-invasive coronary angiography with 16-row multislice Computed Tomography. Radiol Med 2004;107:497-505. (Pubitemid 38937528)
17. Schernthaner R, Stadler A, Lomoschitz F, et al. Multidetector CT angiography in the assessment of peripheral arterial occlusive disease: accuracy in detecting the severity, number, and length of stenoses. Eur Radiol 2008;18:665-71.
18. Fishman EK, Ney DR, Heath DG, et al. Volume rendering versus maximum intensity projection in CT angiography: what works best, when, and why. Radiographics 2006;26:905-22. (Pubitemid 43824984)
19. Portugaller HR, Schoellnast H, Hausegger KA, et al. Multislice spiral CT angiography in peripheral arterial occlusive disease: a valuable tool in detecting significant arterial lumen narrowing? Eur Radiol 2004;14:1681-7.
20. Met R, Bipat S, Legemate DA, et al. Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis. JAMA 2009;301:415-24.
21. Schernthaner R, Fleischmann D, Stadler A, et al. Value of MDCT angiography in developing treatment strategies for critical limb ischemia. AJR Am J Roentgenol 2009;192:1416-24.
22. Schernthaner R, Fleischmann D, Lomoschitz F, et al. Effect of MDCT angiographic findings on the management of intermittent claudication. AJR Am J Roentgenol 2007;189:1215-22. (Pubitemid 350033020)
23. Meyer BC, Werncke T, Hopfenmuller W, et al. Dual energy CT of peripheral arteries: effect of automatic bone and plaque removal on image quality and grading of stenoses. Eur J Radiol 2008;68:414-22.
24. Laird JR. Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries. J Endovasc Ther 2006;13(Suppl 2):II30-40.
25. Blum MB, Schmook M, Schernthaner R, et al. Quantification and detectability of in-stent stenosis with CT angiography and MR angiography in arterial stents in vitro. AJR Am J Roentgenol 2007;189:1238-42. (Pubitemid 350033022)
26. Li XM, Li YH, Tian JM, et al. Evaluation of peripheral artery stent with 64-slice multi-detector row CT angiography: prospective comparison with digital subtraction angiography. Eur J Radiol 2009;75:98-103.
27. Fraioli F, Catalano C, Napoli A, et al. Low-dose multidetector-row CT angiography of the infra-renal aorta and lower extremity vessels: image quality and diagnostic accuracy in comparison with standard DSA. Eur Radiol 2006;16:137-46. (Pubitemid 43103577)
28. Willmann JK, Baumert B, Schertler T, et al. Aortoiliac and lower extremity arteries assessed with 16-detector row CT angiography: prospective comparison with digital subtraction angiography. Radiology 2005;236:1083-93. (Pubitemid 41170877)
29. Muluk SC, Muluk VS, Kelley ME, et al. Outcome events in patients with claudication: a 15-year study in 2777 patients. J Vasc Surg 2001;33:251- 7;discussion 7-8.
30. Thomsen HS, Morcos SK. ESUR guidelines on contrast media. Abdom Imaging 2006;31:131-40.
31. Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med 1990;150:1237-42. (Pubitemid 20188457)
32. Taliercio CP, Vlietstra RE, Fisher LD, et al. Risks for renal dysfunction with cardiac angiography. Ann Intern Med 1986;104:501-4. (Pubitemid 16137810)
33. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996;275:1489-94. (Pubitemid 26140761)
34. Prince MR, Chabra SG, Watts R, et al. Contrast material travel times in patients undergoing peripheral MR angiography. Radiology 2002;224:55-61. (Pubitemid 34680375)
35. Pereles FS, Collins JD, Carr JC, et al. Accuracy of stepping-table lower extremity MR angiography with dual-level bolus timing and separate calf acquisition: hybrid peripheral MR angiography. Radiology 2006;240:283-90. (Pubitemid 43902620)
36. Binkert CA, Baker PD, Petersen BD, et al. Peripheral vascular disease: blinded study of dedicated calf MR angiography versus standard bolus-chase MR angiography and film hard-copy angiography. Radiology 2004;232:860-6.
37. Wang Y, Chen CZ, Chabra SG, et al. Bolus arterial-venous transit in the lower extremity and venous contamination in bolus chase three-dimensional magnetic resonance angiography. Invest Radiol 2002;37:458-63. (Pubitemid 34803864)
38. Morasch MD, Collins J, Pereles FS, et al. Lower extremity stepping-table magnetic resonance angiography with multilevel contrast timing and segmented contrast infusion. J Vasc Surg 2003;37:62-71. (Pubitemid 36236945)
39. Wang Y, Winchester PA, Khilnani NM, et al. Contrast-enhanced peripheral MR angiography from the abdominal aorta to the pedal arteries: combined dynamic two-dimensional and bolus-chase three-dimensional acquisitions. Invest Radiol 2001;36:170-7. (Pubitemid 32209629)
40. Bezooijen R, van den Bosch HC, Tielbeek AV, et al. Peripheral arterial disease: sensitivity-encoded multiposition MR angiography compared with intraarterial angiography and conventional multiposition MR angiography. Radiology 2004;231:263-71. (Pubitemid 38375437)
41. Deutschmann HA, Schoellnast H, Portugaller HR, et al. Routine use of three-dimensional contrast-enhanced moving-table MR angiography in patients with peripheral arterial occlusive disease: comparison with selective digital subtraction angiography. Cardiovasc Intervent Radiol 2006;29:762-70. (Pubitemid 44128007)
42. Ouwendijk R, de Vries M, Pattynama PM, et al. Imaging peripheral arterial disease: a randomized controlled trial comparing contrast-enhanced MR angiography and multi-detector row CT angiography. Radiology 2005;236:1094-103. (Pubitemid 41170878)
43. Lapeyre M, Kobeiter H, Desgranges P, et al. Assessment of critical limb ischemia in patients with diabetes: comparison of MR angiography and digital subtraction angiography. AJR Am J Roentgenol 2005;185:1641-50.
44. Owen RS, Carpenter JP, Baum RA, et al. Magnetic resonance imaging of angiographically occult runoff vessels in peripheral arterial occlusive disease. N Engl J Med 1992;326:1577-81.
45. Baum RA, Rutter CM, Sunshine JH, et al. Multicenter trial to evaluate vascular magnetic resonance angiography of the lower extremity. American College of Radiology Rapid Technology Assessment Group. JAMA 1995;274:875-80.
46. Meissner OA, Rieger J, Weber C, et al. Critical limb ischemia: hybrid MR angiography compared with DSA. Radiology 2005;235:308-18. (Pubitemid 40432268)
47. Kreitner KF, Kalden P, Neufang A, et al. Diabetes and peripheral arterial occlusive disease: prospective comparison of contrast-enhanced three-dimensional MR angiography with conventional digital subtraction angiography. AJR Am J Roentgenol 2000;174:171-9. (Pubitemid 30030230)
48. Owen AR, Robertson IR, Annamalai G, et al. Critical lower-limb ischemia: the diagnostic performance of dual-phase injection MR angiography (including high-resolution distal imaging) compared with digital subtraction angiography. J Vasc Interv Radiol 2009;20:165-72.
49. Cowper SE, Robin HS, Steinberg SM, et al. Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 2000;356:1000-1.
50. Cowper SE. Nephrogenic systemic fibrosis: the nosological and conceptual evolution of nephrogenic fibrosing dermopathy. Am J Kidney Dis 2005;46:763-5. (Pubitemid 41383957)
51. Grobner T. Gadoliniumea specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006;21:1104-8.
52. Marckmann P, Skov L, Rossen K, et al. Case-control study of gadodiamide-related nephrogenic systemic fibrosis. Nephrol Dial Transplant 2007;22:3174-8. (Pubitemid 350202540)
53. Saab G, Abu-Alfa A. Nephrogenic systemic fibrosiseimplications for nephrologists. Eur J Radiol 2008;66:208-12.
54. Morcos SK, Thomsen HS. Nephrogenic systemic fibrosis: more questions and some answers. Nephron Clin Pract 2008;110:c24-31; discussion c2.
55. Nishimura DG. Time-of-flight MR angiography. Magn Reson Med 1990;14:194-201. (Pubitemid 20248605)
56. McCauley TR, Monib A, Dickey K, et al. Peripheral vascular occlusive disease: accuracy and reliability of time-of-flight MR angiography. Radiology 1994;192:351-7.
57. Miyazaki M, Takai H, Sugiura S, et al. Peripheral MR angiography: separation of arteries from veins with flow-spoiled gradient pulses in electrocardiography-triggered three-dimensional half-Fourier fast spin-echo imaging. Radiology 2003;227:890-6. (Pubitemid 36583053)